Critical role of HMGA proteins in cancer cell chemoresistance

被引：19

作者：

D'Angelo, Daniela ^{[1
]}

Mussnich, Paula ^{[1
]}

Arra, Claudio ^{[2
]}

Battista, Sabrina ^{[1
]}

Fusco, Alfredo ^{[1
,3
]}

机构：

[1] Ist Endocrinol & Oncol Sperimentale CNR, Via Pansini 5, I-80131 Naples, Italy

[2] IRCCS, Ist Nazl Studio & Cura Tumori Fdn Giovanni Pascal, Naples, Italy

[3] Univ Napoli Federico II, DMMBM, Via Pansini 5, I-80131 Naples, Italy

来源：

JOURNAL OF MOLECULAR MEDICINE-JMM | 2017年 / 95卷 / 04期

关键词：

HMGA; Chemoresistance; DNA repair; Apoptosis; miRNAs; GROUP-A PROTEINS; PHASE-II TRIAL; TRANSGENIC MICE; DRUG-RESISTANCE; UP-REGULATION; CISPLATIN RESISTANCE; MULTIDRUG-RESISTANCE; COLORECTAL-CANCER; CARCINOMA CELLS; DOWN-REGULATION;

D O I：

10.1007/s00109-017-1520-x

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

The high-mobility group A (HMGA) proteins are frequently overexpressed in human malignancies and correlate with the presence of metastases and reduced patient survival. Here, we highlight the main studies evidencing a critical role of HMGA in chemoresistance, mainly by activating Akt signaling, impairing p53 activity, and regulating the expression of microRNAs that target genes involved in the susceptibility of cancer cells to antineoplastic agents. Therefore, these studies account for the association of HMGA overexpression with patient poor outcome, indicating the impairment of HMGA as a fascinating perspective for effectively improving cancer therapy.

引用

页码：353 / 360

页数：8

共 75 条

[1] Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4 [J].

Ahmad, Aamir ;

Ginnebaugh, Kevin R. ;

Yin, Shuping ;

Bollig-Fischer, Aliccia ;

Reddy, Kaladhar B. ;

Sarkar, Fazlul H. .

BMC CANCER, 2015, 15

[2] The rise of DNA methylation and the importance of chromatin on multidrug resistance in cancer [J].

Baker, EK ;

El-Osta, A .

EXPERIMENTAL CELL RESEARCH, 2003, 290 (02) :177-194

[3] Negative regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein levels in sporadic breast carcinoma [J].

Baldassarre, G ;

Battista, S ;

Belletti, B ;

Thakur, S ;

Pentimalli, F ;

Trapasso, F ;

Fedele, M ;

Pierantoni, G ;

Croce, CM ;

Fusco, A .

MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (07) :2225-2238

[4] Onset of natural killer cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway [J].

Baldassarre, G ;

Fedele, M ;

Battista, S ;

Vecchione, A ;

Klein-Szanto, AJP ;

Santoro, M ;

Waldmann, TA ;

Azimi, N ;

Croce, CM ;

Fusco, A .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (14) :7970-7975

[5] Phase II trial of salvage therapy with trabectedin in metastatic pancreatic adenocarcinoma [J].

Belli, Carmen ;

Piemonti, Lorenzo ;

D'Incalci, Maurizio ;

Zucchetti, Massimo ;

Porcu, Luca ;

Cappio, Stefano ;

Doglioni, Claudio ;

Allavena, Paola ;

Ceraulo, Domenica ;

Maggiora, Paola ;

Dugnani, Erica ;

Cangi, Maria Giulia ;

Garassini, Greta ;

Reni, Michele .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (03) :477-484

[6] HMGA1 Induces Intestinal Polyposis in Transgenic Mice and Drives Tumor Progression and Stem Cell Properties in Colon Cancer Cells [J].

Belton, Amy ;

Gabrovsky, Alexander ;

Bae, Young Kyung ;

Reeves, Ray ;

Iacobuzio-Donahue, Christine ;

Huso, David L. ;

Resar, Linda M. S. .

PLOS ONE, 2012, 7 (01)

[7]

BERLINGIERI MT, 1995, MOL CELL BIOL, V15, P1545

[8] A phase II trial of trabectedin in triple-negative and HER2-overexpressing metastatic breast cancer [J].

Blum, Joanne L. ;

Goncalves, Anthony ;

Efrat, Noa ;

Debled, Marc ;

Conte, Pierfranco ;

Richards, Paul D. ;

Richards, Donald ;

Lardelli, Pilar ;

Nieto, Antonio ;

Cullell-Young, Martin ;

Delaloge, Suzette .

BREAST CANCER RESEARCH AND TREATMENT, 2016, 155 (02) :295-302

[9] High mobility group A2 protein and its derivatives bind a specific region of the promoter of DNA repair gene ERCC1 and modulate its activity [J].

Borrmann, L ;

Schwanbeck, R ;

Heyduk, T ;

Seebeck, B ;

Rogalla, P ;

Bullerdiek, J ;

Wisniewski, JR .

NUCLEIC ACIDS RESEARCH, 2003, 31 (23) :6841-6851

[10] The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance [J].

Bouwman, Peter ;

Jonkers, Jos .

NATURE REVIEWS CANCER, 2012, 12 (09) :587-598

← 1 2 3 4 5 6 7 8 →